Sutton Wealth Advisors Inc. Spectrum Pharmaceuticals Inc Transaction History

Sutton Wealth Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 07, 2023	SELL	$2.15 - $3.82 $6,353 - $11,288	-2,955 Closed	0 $0
Q2 2020 Nov 07, 2023	BUY	$2.11 - $3.38 $1,996 - $3,197	946 Added 47.09%	2,955 $9.99 Million
Q1 2020 Nov 07, 2023	SELL	$1.83 - $3.45 $1,233 - $2,325	-674 Reduced 25.12%	2,009 $4.68 Million
Q1 2018 Nov 06, 2023	SELL	$16.09 - $23.07 $386 - $553	-24 Reduced 0.89%	2,683 $43.2 Million
Q4 2017 Nov 06, 2023	SELL	$13.36 - $20.73 $4,021 - $6,239	-301 Reduced 10.01%	2,707 $51.3 Million
Q4 2016 Nov 06, 2023	BUY	N/A	3,008 New	3,008 $13.3 Million
Q3 2016 Nov 06, 2023	SELL	N/A	-993 Closed	0 $0
Q1 2016 Nov 06, 2023	BUY	N/A	993	993 $6.32 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.